Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 10/31/2025
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 130 publications
Carpal Tunnel Syndrome Attributed to Medication Use: A Pharmacovigilance Study.
Journal: Cureus
Published: May 12, 2025
Safety assessment of laronidase: real-world adverse event analysis based on the FDA adverse event reporting system (FAERS).
Journal: Frontiers in pharmacology
Published: May 06, 2025
Efficacy and safety of a biosimilar laronidase versus the reference laronidase in patients with mucopolysaccharidosis type I.
Journal: Scientific reports
Published: April 06, 2025
Laronidase-loaded liposomes reach the brain and other hard-to-treat organs after noninvasive nasal administration.
Journal: International journal of pharmaceutics
Published: April 04, 2024
Two-year follow-up after drug desensitization in mucopolysaccharidosis.
Journal: Orphanet journal of rare diseases
Published: March 09, 2024
Efficacy of a Combination Therapy with Laronidase and Genistein in Treating Mucopolysaccharidosis Type I in a Mouse Model.
Journal: International journal of molecular sciences
Published: December 27, 2023
α-L-iduronidase fused with humanized anti-human transferrin receptor antibody (lepunafusp alfa) for mucopolysaccharidosis type I: A phase 1/2 trial.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: October 10, 2023
Evaluation of etanercept (a tumor necrosis factor alpha inhibitor) as an effective treatment for joint disease in mucopolysaccharidosis type I. A case report with whole-body magnetic resonance imaging.
Journal: Frontiers in medicine
Published: July 04, 2023
Safety outcomes and patients' preferences for home-based intravenous enzyme replacement therapy (ERT) in pompe disease and mucopolysaccharidosis type I (MPS I) disorder: COVID-19 and beyond.
Journal: Orphanet journal of rare diseases
Published: June 28, 2023
Novel approach to idursulfase and laronidase desensitization in type 2 and type 1 S mucopolysaccharidosis (MPS).
Journal: Orphanet journal of rare diseases
Published: August 01, 2022
18-year follow-up of enzyme-replacement therapy in two siblings with attenuated mucopolysaccharidosis I.
Journal: American journal of medical genetics. Part A
Published: July 11, 2022
Treatment of latent tuberculosis in a child with mucopolysaccharidosis type I receiving enzyme replacement therapy: A case report.
Journal: Frontiers in pediatrics
Published: June 19, 2022
Last Updated: 10/31/2025